Samsung Fire & Marine Insurance Secures 3-Month Exclusive Rights for New Bojeong Account Coverage

Samsung Fire & Marine Insurance announced on June 13 that it has obtained exclusive usage rights from the General Insurance Association of Korea's New Product Review Committee for new coverage and services included in its new health insurance product, Bojeong Account.

The coverage and services granted exclusive usage rights are "Specific Test Expenses for Cancer, Cerebrovascular, and Ischemic Diseases" and "Severe Disease Hospital Companion Service," each granted for a period of three months.

The "Specific Test Expenses for Cancer, Cerebrovascular, and Ischemic Diseases" provides insurance payouts for tests conducted for the purpose of treatment and follow-up of cancer or cerebrovascular and ischemic diseases. It comprehensively covers a wide range of tests, including MRI and CT scans, as well as everything from prevention to follow-up management of severe diseases.

For the first time in the industry, the company differentiated coverage for test expenses based on whether special benefit criteria apply, thereby reducing customers' actual medical expenses.

The "Severe Disease Hospital Companion Service" is a dedicated companion service for medically vulnerable individuals who have difficulty visiting hospitals, in line with the increasing number of single-person households and the aging society.

For the first time in the industry, the service is provided from the stage when a severe disease is suspected, offering consultation, hospital reservation, and companion services from the moment customers experience significant anxiety. To enhance convenience, family members or insurance planners can apply on behalf of the customer, and the service includes location notifications during hospital visits and a results report after the visit.

A Samsung Fire & Marine Insurance representative stated, "We have launched new coverage and services that are easy for customers and sellers to understand and that provide the essential protection needed during the treatment of cancer, brain, and heart diseases," adding, "We will continue to offer products that not only provide risk coverage but also take responsibility for prevention and post-management of diseases for our customers."

This content was produced with the assistance of AI translation services.